BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25491796)

  • 1. Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails.
    Morawska-Chochół A; Domalik-Pyzik P; Chłopek J; Szaraniec B; Sterna J; Rzewuska M; Boguń M; Kucharski R; Mielczarek P
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():15-20. PubMed ID: 25491796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the intramedullary nail preparation method on nail's mechanical properties and degradation rate.
    Morawska-Chochół A; Chłopek J; Szaraniec B; Domalik-Pyzik P; Balacha E; Boguń M; Kucharski R
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():99-106. PubMed ID: 25842113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium alloy wires as reinforcement in composite intramedullary nails.
    Morawska-Chochół A; Chłopek J; Domalik-Pyzik P; Szaraniec B; Grzyśka E
    Biomed Mater Eng; 2014; 24(2):1507-15. PubMed ID: 24642977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin-Loaded Polysaccharide Membranes for Prevention and Treatment of Post-operative Wound Infections in the Skeletal System.
    Cibor U; Krok-Borkowicz M; Brzychczy-Włoch M; Rumian Ł; Pietryga K; Kulig D; Chrzanowski W; Pamuła E
    Pharm Res; 2017 Oct; 34(10):2075-2083. PubMed ID: 28639052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite material consisting of microporous β-TCP ceramic and alginate for delayed release of antibiotics.
    Seidenstuecker M; Ruehe J; Suedkamp NP; Serr A; Wittmer A; Bohner M; Bernstein A; Mayr HO
    Acta Biomater; 2017 Mar; 51():433-446. PubMed ID: 28104468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable intramedullary nails reinforced with carbon and alginate fibers: In vitro and in vivo biocompatibility.
    Morawska-Chochół A; Domalik-Pyzik P; Menaszek E; Sterna J; Bielecki W; Bonecka J; Boguń M; Chłopek J
    J Appl Biomater Funct Mater; 2018 Jan; 16(1):36-41. PubMed ID: 28623633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review.
    Schmidmaier G; Lucke M; Wildemann B; Haas NP; Raschke M
    Injury; 2006 May; 37 Suppl 2():S105-12. PubMed ID: 16651063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and in vitro release of gentamicin from coralline hydroxyapatite-alginate composite microspheres.
    Sivakumar M; Rao KP
    J Biomed Mater Res A; 2003 May; 65(2):222-8. PubMed ID: 12734816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
    Ahola N; Männistö N; Veiranto M; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2013; 3(2):. PubMed ID: 23507926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A composite coating of calcium alginate and gelatin particles on Ti6Al4V implant for the delivery of water soluble drug.
    Xiao J; Zhu Y; Liu Y; Zeng Y; Xu F
    J Biomed Mater Res B Appl Biomater; 2009 May; 89(2):543-550. PubMed ID: 19048634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants.
    Lan SF; Kehinde T; Zhang X; Khajotia S; Schmidtke DW; Starly B
    Dent Mater; 2013 Jun; 29(6):656-65. PubMed ID: 23602170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
    Zhu CT; Xu YQ; Shi J; Li J; Ding J
    Drug Deliv; 2010 Aug; 17(6):391-8. PubMed ID: 20429845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.
    Ahola N; Veiranto M; Männistö N; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2012; 2(4):213-25. PubMed ID: 23507887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis.
    Giavaresi G; Bertazzoni Minelli E; Sartori M; Benini A; Della Bora T; Sambri V; Gaibani P; Borsari V; Salamanna F; Martini L; Nicoli Aldini N; Fini M
    J Orthop Res; 2012 Mar; 30(3):348-55. PubMed ID: 21882237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing.
    De Cicco F; Porta A; Sansone F; Aquino RP; Del Gaudio P
    Int J Pharm; 2014 Oct; 473(1-2):30-7. PubMed ID: 24979533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers.
    Chang HI; Lau YC; Yan C; Coombes AG
    J Biomed Mater Res A; 2008 Jan; 84(1):230-7. PubMed ID: 17607742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intramedullary nail coated with antibiotic and growth factor nanoparticles: An individualized state-of-the-art treatment for chronic osteomyelitis with bone defects.
    Berebichez-Fridman R; Montero-Olvera P; Gómez-García R; Berebichez-Fastlicht E
    Med Hypotheses; 2017 Aug; 105():63-68. PubMed ID: 28735655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.
    Zhang X; Wyss UP; Pichora D; Goosen MF
    J Pharm Pharmacol; 1994 Sep; 46(9):718-24. PubMed ID: 7837040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro characterization of gentamycin-impregnated biodegradable beads suitable for treatment of osteomyelitis.
    Meyer JD; Falk RF; Kelly RM; Shively JE; Withrow SJ; Dernell WS; Kroll DJ; Randolph TW; Manning MC
    J Pharm Sci; 1998 Sep; 87(9):1149-54. PubMed ID: 9724569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolytic degradation of composites of poly(L-lactide-co-epsilon-caprolactone) 70/30 and β-tricalcium phosphate.
    Ahola N; Veiranto M; Rich J; Efimov A; Hannula M; Seppälä J; Kellomäki M
    J Biomater Appl; 2013 Nov; 28(4):529-43. PubMed ID: 23048066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.